Literature DB >> 22480372

Protein-ligand-based pharmacophores: generation and utility assessment in computational ligand profiling.

Jamel Meslamani1, Jiabo Li, Jon Sutter, Adrian Stevens, Hugues-Olivier Bertrand, Didier Rognan.   

Abstract

Ligand profiling is an emerging computational method for predicting the most likely targets of a bioactive compound and therefore anticipating adverse reactions, side effects and drug repurposing. A few encouraging successes have already been reported using ligand 2-D similarity searches and protein-ligand docking. The current study describes the use of receptor-ligand-derived pharmacophore searches as a tool to link ligands to putative targets. A database of 68,056 pharmacophores was first derived from 8,166 high-resolution protein-ligand complexes. In order to limit the number of queries, a maximum of 10 pharmacophores was generated for each complex according to their predicted selectivity. Pharmacophore search was compared to ligand-centric (2-D and 3-D similarity searches) and docking methods in profiling a set of 157 diverse ligands against a panel of 2,556 unique targets of known X-ray structure. As expected, ligand-based methods outperformed, in most of the cases, structure-based approaches in ranking the true targets among the top 1% scoring entries. However, we could identify ligands for which only a single method was successful. Receptor-ligand-based pharmacophore search is notably a fast and reliable alternative to docking when few ligand information is available for some targets. Overall, the present study suggests that a workflow using the best profiling method according to the protein-ligand context is the best strategy to follow. We notably present concrete guidelines for selecting the optimal computational method according to simple ligand and binding site properties.

Mesh:

Substances:

Year:  2012        PMID: 22480372     DOI: 10.1021/ci300083r

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  30 in total

1.  Pharmacophore and molecular dynamics based activity profiling of natural products for kinases involved in lung cancer.

Authors:  Pankaj Kumar Singh; Om Silakari
Journal:  J Mol Model       Date:  2018-10-20       Impact factor: 1.810

2.  Receptor pharmacophore ensemble (REPHARMBLE): a probabilistic pharmacophore modeling approach using multiple protein-ligand complexes.

Authors:  Sivakumar Prasanth Kumar
Journal:  J Mol Model       Date:  2018-09-15       Impact factor: 1.810

3.  Identification of new promising Plasmodium falciparum superoxide dismutase allosteric inhibitors through hierarchical pharmacophore-based virtual screening and molecular dynamics.

Authors:  Janay Stefany Carneiro Araujo; Bruno Cruz de Souza; David Bacelar Costa Junior; Larissa de Mattos Oliveira; Isis Bugia Santana; Angelo Amâncio Duarte; Pedro Sousa Lacerda; Manoelito Coelho Dos Santos Junior; Franco Henrique Andrade Leite
Journal:  J Mol Model       Date:  2018-07-28       Impact factor: 1.810

4.  A Computational Approach with Biological Evaluation: Combinatorial Treatment of Curcumin and Exemestane Synergistically Regulates DDX3 Expression in Cancer Cell Lines.

Authors:  Shailima Rampogu; Seong Min Kim; Minky Son; Ayoung Baek; Chanin Park; Gihwan Lee; Yumi Kim; Gon Sup Kim; Ju Hyun Kim; Keun Woo Lee
Journal:  Biomolecules       Date:  2020-06-04

5.  Dispensing processes impact apparent biological activity as determined by computational and statistical analyses.

Authors:  Sean Ekins; Joe Olechno; Antony J Williams
Journal:  PLoS One       Date:  2013-05-01       Impact factor: 3.240

6.  Benchmarking of protein descriptor sets in proteochemometric modeling (part 1): comparative study of 13 amino acid descriptor sets.

Authors:  Gerard Jp van Westen; Remco F Swier; Jörg K Wegner; Adriaan P Ijzerman; Herman Wt van Vlijmen; Andreas Bender
Journal:  J Cheminform       Date:  2013-09-23       Impact factor: 5.514

7.  Benchmarking of protein descriptor sets in proteochemometric modeling (part 2): modeling performance of 13 amino acid descriptor sets.

Authors:  Gerard Jp van Westen; Remco F Swier; Isidro Cortes-Ciriano; Jörg K Wegner; John P Overington; Adriaan P Ijzerman; Herman Wt van Vlijmen; Andreas Bender
Journal:  J Cheminform       Date:  2013-09-24       Impact factor: 5.514

8.  Pharmacophore Modelling-Based Drug Repurposing Approaches for SARS-CoV-2 Therapeutics.

Authors:  Shailima Rampogu; Keun Woo Lee
Journal:  Front Chem       Date:  2021-05-10       Impact factor: 5.221

9.  Physicochemical characteristics of structurally determined metabolite-protein and drug-protein binding events with respect to binding specificity.

Authors:  Paula Korkuć; Dirk Walther
Journal:  Front Mol Biosci       Date:  2015-09-15

10.  Prospective performance evaluation of selected common virtual screening tools. Case study: Cyclooxygenase (COX) 1 and 2.

Authors:  Teresa Kaserer; Veronika Temml; Zsofia Kutil; Tomas Vanek; Premysl Landa; Daniela Schuster
Journal:  Eur J Med Chem       Date:  2015-04-08       Impact factor: 6.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.